BCAB
Bioatla
$3.40
+$0.03 (+0.89%)Jul 27, 2026
Key metrics
The numbers that frame BCAB today
- Market cap
- $5.63M
- P/E (TTM)
- -0.1
- EV / FCF
- -0.3
- Gross margin
- 100%
- EV / Sales
- 4.9
- ROIC
- 886%
- Div yield
- 0%
- 52wk Low
- $3.12
- 52wk High
- $71.50
Growth
Revenue and earnings trend for BCAB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BCAB
Is Bioatla a good buy?
No. Bioatla has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Bioatla is selling at a very high price.
What is the market capitalization of BCAB?
Bioatla's market capitalization is $5.63M.
What is the P/E ratio for BCAB stock?
Bioatla's current P/E ratio is -0.1.
What is the 52-week high for BCAB stock?
The 52-week high for Bioatla is $71.50. The current close of $3.40 is 95.2% below that high.
What is the 52-week low for BCAB stock?
The 52-week low for Bioatla is $3.12. The current close of $3.40 is 9% above that low.
Does BCAB stock pay dividends?
Bioatla does not currently show a dividend per share in the company data.